Inhibition of NOX/VPO1 pathway and inflammatory reaction by trimethoxystilbene in prevention of cardiovascular remodeling in hypoxia-induced pulmonary hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 63, Issue 6, 2014, Pages 567-576

  Liu, Bin ^a   Luo, Xiu Ju ^a   Yang, Zhong Bao ^a   Zhang, Jie Jie ^a   Li, Ting Bo ^a   Zhang, Xiao Jie ^a   Ma, Qi Lin ^b   Zhang, Guo Gang ^b   Hu, Chang Ping ^a   Peng, Jun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Pulmonary arterial hypertension; Pulmonary vascular remodeling; Resveratrol analog; Right ventricular hypertrophy; Trimethoxystilbene

Indexed keywords

BETA ACTIN; CD68 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; HYDROGEN PEROXIDE; MESSENGER RNA; PEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; RESVERATROL; STILBENE DERIVATIVE; TRIMETHOXYSTILBENE; UNCLASSIFIED DRUG; VASCULAR PEROXIDASE 1; CYBB PROTEIN, RAT; HEMOPROTEIN; MEMBRANE PROTEIN; NOX4 PROTEIN, RAT; VASCULAR PEROXIDASE, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD VESSEL DIAMETER; CELL INFILTRATION; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; HEART RIGHT VENTRICLE HYPERTROPHY; HYPOXIA; INFLAMMATORY CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; ANIMAL; ANOXIA; ANTAGONISTS AND INHIBITORS; CHEMISTRY; COMPLICATION; DRUG EFFECTS; ENZYMOLOGY; HEART VENTRICLE REMODELING; HYPERTENSION, PULMONARY; INFLAMMATION; METABOLISM; PHYSIOLOGY; RANDOMIZATION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ANOXIA; HEMEPROTEINS; HYPERTENSION, PULMONARY; INFLAMMATION; MALE; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; PEROXIDASES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STILBENES; VENTRICULAR REMODELING;

EID: 84902291386     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000082     Document Type: Article

References (38)

1. Chin KM, Rubin LJ. Pulmonary arterial hypertension. J Am Coll Cardiol. 2008;51:1527-1538.
2. Morrell NW, Adnot S, Archer SL, et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54:S20-S31.
3. Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation. 2004;109:159-165.
4. Franco V. Right ventricular remodeling in pulmonary hypertension. Heart Fail Clin. 2012;8:403-412.
5. Shimoda LA, Laurie SS. Vascular remodeling in pulmonary hypertension. J Mol Med (Berl). 2013;91:297-309.
6. Chin KM, Kim NH, Rubin LJ. The right ventricle in pulmonary hypertension. Coron Artery Dis. 2005;16:13-18.
7. Sahara M, Takahashi T, Imai Y, et al. New insights in the treatment strategy for pulmonary arterial hypertension. Cardiovasc Drugs Ther. 2006;20:377-386.
8. Demarco VG, Whaley-Connell AT, Sowers JR, et al. Contribution of oxidative stress to pulmonary arterial hypertension. World J Cardiol. 2010;2:316-324.
9. Tabima DM, Frizzell S, Gladwin MT. Reactive oxygen and nitrogen species in pulmonary hypertension. Free Radic Biol Med. 2012;52: 1970-1986.
10. Ma QL, Zhang GG, Peng J. Vascular peroxidase 1: a novel enzyme in promoting oxidative stress in cardiovascular system. Trends Cardiovasc Med. 2013;23:179-183.
11. Zhang YS, He L, Liu B, et al. A novel pathway of NADPH oxidase/vascular peroxidase 1 in mediating oxidative injury following ischemiareperfusion. Basic Res Cardiol. 2012;107:266.
12. Li TT, Zhang YS, He L, et al. Inhibition of vascular peroxidase alleviates cardiac dysfunction and apoptosis induced by ischemia-reperfusion. Can J Physiol Pharmacol. 2012;90:851-862.
13. Shi R, Hu C, Yuan Q, et al. Involvement of vascular peroxidase 1 in angiotensin II-induced vascular smooth muscle cell proliferation. Cardiovasc Res. 2011;91:27-36.
14. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5:493-506.
15. Li H, Xia N, Forstermann U. Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide. 2012;26:102-110.
16. Csiszar A, Labinskyy N, Olson S, et al. Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension. 2009;54:668-675.
17. Gao G, Wang X, Qin X, et al. Effects of trimethoxystilbene on proliferation and apoptosis of pulmonary artery smooth muscle cells. Cell Biochem Biophys. 2012;64:101-106.
18. Li J, Rao J, Liu Y, et al. 15-Lipoxygenase promotes chronic hypoxiainduced pulmonary artery inflammation via positive interaction with nuclear factor-kappaB. Arterioscler Thromb Vasc Biol. 2013;33:971-979.
19. Martyn KD, Frederick LM, von Loehneysen K, et al. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal. 2006;18:69-82.
20. Takac I, Schroder K, Zhang L, et al. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J Biol Chem. 2011; 286:13304-13313.
21. DeMarco VG, Habibi J, Whaley-Connell AT, et al. Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat. Am J Physiol Heart Circ Physiol. 2008;294:H2659-H2668.
22. Grobe AC, Wells SM, Benavidez E, et al. Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: role of NADPH oxidase and endothelial NO synthase. Am J Physiol Lung Cell Mol Physiol. 2006;290:L1069-L1077.
23. Hoshikawa Y, Ono S, Suzuki S, et al. Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia. J Appl Physiol (1985). 2001;90:1299-1306.
24. Matsui H, Shimosawa T, Itakura K, et al. Adrenomedullin can protect against pulmonary vascular remodeling induced by hypoxia. Circulation. 2004;109:2246-2251.
25. Farahmand F, Hill MF, Singal PK. Antioxidant and oxidative stress changes in experimental cor pulmonale. Mol Cell Biochem. 2004;260:21-29.
26. Wong CM, Bansal G, Pavlickova L, et al. Reactive oxygen species and antioxidants in pulmonary hypertension. Antioxid Redox Signal. 2013;18: 1789-1796.
27. Fike CD, Dikalova A, Slaughter JC, et al. Reactive oxygen speciesreducing strategies improve pulmonary arterial responses to nitric oxide in piglets with chronic hypoxia-induced pulmonary hypertension. Antioxid Redox Signal. 2013;18:1727-1738.
28. Bhatt SR, Lokhandwala MF, Banday AA. Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. Eur J Pharmacol. 2011;667:258-264.
29. Norata GD, Marchesi P, Passamonti S, et al. Anti-inflammatory and antiatherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis. 2007;191:265-271.
30. Shen M, Wu RX, Zhao L, et al. Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism. PLoS One. 2012;7:e51223.
31. Su HC, Hung LM, Chen JK. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab. 2006;290:E1339-E1346.
32. Yang DL, Zhang HG, Xu YL, et al. Resveratrol inhibits right ventricular hypertrophy induced by monocrotaline in rats. Clin Exp Pharmacol Physiol. 2010;37:150-155.
33. Manea A. NADPH oxidase-derived reactive oxygen species:involvement in vascular physiology and pathology. Cell Tissue Res. 2010;342:325-339.
34. Cheng G, Salerno JC, Cao Z, et al. Identification and characterization of VPO1, a new animal heme-containing peroxidase. Free Radic Biol Med. 2008;45:1682-1694.
35. Li H, Cao Z, Zhang G, et al. Vascular peroxidase 1 catalyzes the formation of hypohalous acids:characterization of its substrate specificity and enzymatic properties. Free Radic Biol Med. 2012;53:1954-1959.
36. Bai YP, Hu CP, Yuan Q, et al. Role of VPO1, a newly identified hemecontaining peroxidase, in ox-LDL induced endothelial cell apoptosis. Free Radic Biol Med. 2011;51:1492-1500.
37. Wind S, Beuerlein K, Armitage ME, et al. Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition. Hypertension. 2010;56:490-497.
38. Briones AM, Rodriguez-Criado N, Hernanz R, et al. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress. Hypertension. 2009;54:142-149.